Annual Revenue
$33.72 B
+$8.64 B+34.43%
31 December 2023
Summary
Novo Nordisk A/S annual revenue is currently $33.72 billion, with the most recent change of +$8.64 billion (+34.43%) on 31 December 2023. During the last 3 years, it has risen by +$14.27 billion (+73.37%). NVO annual revenue is now at all-time high.NVO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$10.51 B
+$685.15 M+6.97%
30 September 2024
Summary
Novo Nordisk A/S quarterly revenue is currently $10.51 billion, with the most recent change of +$685.15 million (+6.97%) on 30 September 2024. Over the past year, it has increased by +$1.93 billion (+22.53%). NVO quarterly revenue is now at all-time high.NVO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$39.36 B
+$1.93 B+5.16%
30 September 2024
Summary
Novo Nordisk A/S TTM revenue is currently $39.36 billion, with the most recent change of +$1.93 billion (+5.16%) on 30 September 2024. Over the past year, it has increased by +$8.54 billion (+27.70%). NVO TTM revenue is now at all-time high.NVO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Revenue Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +34.4% | +22.5% | +27.7% |
3 y3 years | +73.4% | +86.1% | +82.0% |
5 y5 years | +90.4% | +133.0% | +118.3% |
NVO Revenue High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +73.4% | at high | +86.1% | at high | +82.0% |
5 y | 5 years | at high | +90.4% | at high | +137.2% | at high | +118.3% |
alltime | all time | at high | +9135.9% | at high | >+9999.0% | at high | >+9999.0% |
Novo Nordisk A/S Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $10.51 B(+7.0%) | $39.36 B(+5.2%) |
June 2024 | - | $9.82 B(+3.2%) | $37.42 B(+5.3%) |
Mar 2024 | - | $9.52 B(+0.1%) | $35.54 B(+5.4%) |
Dec 2023 | $33.72 B(+34.4%) | $9.51 B(+10.8%) | $33.71 B(+9.4%) |
Sept 2023 | - | $8.58 B(+8.1%) | $30.82 B(+8.5%) |
June 2023 | - | $7.94 B(+3.1%) | $28.41 B(+7.7%) |
Mar 2023 | - | $7.70 B(+16.4%) | $26.38 B(+5.4%) |
Dec 2022 | $25.09 B(+12.0%) | $6.61 B(+7.2%) | $25.03 B(+2.9%) |
Sept 2022 | - | $6.17 B(+4.4%) | $24.31 B(+2.2%) |
June 2022 | - | $5.91 B(-6.8%) | $23.79 B(+2.4%) |
Mar 2022 | - | $6.34 B(+7.5%) | $23.24 B(+3.8%) |
Dec 2021 | $22.40 B(+15.2%) | $5.90 B(+4.4%) | $22.38 B(+3.5%) |
Sept 2021 | - | $5.65 B(+5.5%) | $21.63 B(+3.8%) |
June 2021 | - | $5.35 B(-2.3%) | $20.84 B(+4.6%) |
Mar 2021 | - | $5.48 B(+6.4%) | $19.92 B(+2.5%) |
Dec 2020 | $19.45 B(+6.3%) | $5.15 B(+6.0%) | $19.44 B(+1.8%) |
Sept 2020 | - | $4.86 B(+9.6%) | $19.10 B(+1.9%) |
June 2020 | - | $4.43 B(-11.4%) | $18.75 B(-0.5%) |
Mar 2020 | - | $5.00 B(+4.1%) | $18.84 B(+3.0%) |
Dec 2019 | $18.30 B(+3.3%) | $4.81 B(+6.5%) | $18.29 B(+1.4%) |
Sept 2019 | - | $4.51 B(-0.2%) | $18.03 B(+1.0%) |
June 2019 | - | $4.52 B(+1.4%) | $17.85 B(+0.7%) |
Mar 2019 | - | $4.46 B(-1.9%) | $17.72 B(+0.1%) |
Dec 2018 | $17.71 B(+4.2%) | $4.55 B(+5.0%) | $17.71 B(+0.7%) |
Sept 2018 | - | $4.33 B(-1.4%) | $17.59 B(+0.7%) |
June 2018 | - | $4.39 B(-1.2%) | $17.47 B(+0.9%) |
Mar 2018 | - | $4.44 B(+0.3%) | $17.31 B(+2.2%) |
Dec 2017 | $17.00 B(+2.3%) | $4.43 B(+5.3%) | $16.95 B(+0.8%) |
Sept 2017 | - | $4.21 B(-0.7%) | $16.80 B(+0.5%) |
June 2017 | - | $4.23 B(+3.9%) | $16.73 B(+0.4%) |
Mar 2017 | - | $4.08 B(-4.9%) | $16.66 B(+0.3%) |
Dec 2016 | $16.61 B(+3.5%) | $4.29 B(+3.8%) | $16.61 B(+0.3%) |
Sept 2016 | - | $4.13 B(-0.9%) | $16.56 B(+0.8%) |
June 2016 | - | $4.17 B(+3.6%) | $16.42 B(+1.0%) |
Mar 2016 | - | $4.02 B(-5.0%) | $16.25 B(+1.3%) |
Dec 2015 | $16.06 B(+1.4%) | $4.23 B(+6.1%) | $16.05 B(+0.7%) |
Sept 2015 | - | $3.99 B(-0.4%) | $15.94 B(+0.2%) |
June 2015 | - | $4.01 B(+5.0%) | $15.91 B(+0.2%) |
Mar 2015 | - | $3.82 B(-7.5%) | $15.87 B(+0.5%) |
Dec 2014 | $15.84 B(+6.4%) | $4.13 B(+4.3%) | $15.79 B(+1.1%) |
Sept 2014 | - | $3.96 B(-0.5%) | $15.62 B(+2.0%) |
June 2014 | - | $3.97 B(+6.4%) | $15.31 B(+1.5%) |
Mar 2014 | - | $3.73 B(-5.7%) | $15.08 B(+1.3%) |
Dec 2013 | $14.88 B(+10.4%) | $3.96 B(+8.6%) | $14.89 B(+2.2%) |
Sept 2013 | - | $3.65 B(-2.7%) | $14.57 B(+2.2%) |
June 2013 | - | $3.75 B(+5.9%) | $14.26 B(+2.8%) |
Mar 2013 | - | $3.54 B(-3.0%) | $13.87 B(+3.0%) |
Dec 2012 | $13.47 B(+8.7%) | $3.64 B(+9.4%) | $13.47 B(+2.8%) |
Sept 2012 | - | $3.33 B(-0.9%) | $13.10 B(+1.5%) |
June 2012 | - | $3.36 B(+7.4%) | $12.91 B(+2.2%) |
Mar 2012 | - | $3.13 B(-4.6%) | $12.63 B(+2.0%) |
Dec 2011 | $12.39 B(+14.5%) | $3.28 B(+4.6%) | $12.38 B(+2.9%) |
Sept 2011 | - | $3.14 B(+1.5%) | $12.04 B(+3.7%) |
June 2011 | - | $3.09 B(+7.3%) | $11.60 B(+4.1%) |
Mar 2011 | - | $2.88 B(-1.9%) | $11.15 B(+3.1%) |
Dec 2010 | $10.82 B(+13.2%) | $2.94 B(+8.7%) | $10.81 B(+3.3%) |
Sept 2010 | - | $2.70 B(+2.7%) | $10.47 B(+2.9%) |
June 2010 | - | $2.63 B(+3.4%) | $10.17 B(+2.5%) |
Mar 2010 | - | $2.54 B(-1.9%) | $9.92 B(+3.7%) |
Dec 2009 | $9.56 B(+6.3%) | $2.59 B(+7.8%) | $9.57 B(+3.8%) |
Sept 2009 | - | $2.40 B(+1.1%) | $9.22 B(+1.6%) |
June 2009 | - | $2.38 B(+8.6%) | $9.08 B(+0.6%) |
Mar 2009 | - | $2.19 B(-2.3%) | $9.02 B(+0.6%) |
Dec 2008 | $9.00 B(+16.8%) | $2.24 B(-0.9%) | $8.97 B(+1.2%) |
Sept 2008 | - | $2.26 B(-2.8%) | $8.87 B(+3.8%) |
June 2008 | - | $2.33 B(+9.1%) | $8.54 B(+5.1%) |
Mar 2008 | - | $2.13 B(-0.3%) | $8.12 B(+5.3%) |
Dec 2007 | $7.70 B(+18.0%) | $2.14 B(+10.4%) | $7.72 B(+4.4%) |
Sept 2007 | - | $1.94 B(+1.4%) | $7.39 B(+4.3%) |
June 2007 | - | $1.91 B(+10.8%) | $7.09 B(+4.0%) |
Mar 2007 | - | $1.73 B(-4.9%) | $6.82 B(+4.3%) |
Dec 2006 | $6.53 B(+15.9%) | $1.81 B(+10.8%) | $6.54 B(+5.1%) |
Sept 2006 | - | $1.64 B(-0.2%) | $6.22 B(+3.3%) |
June 2006 | - | $1.64 B(+13.7%) | $6.02 B(+4.2%) |
Mar 2006 | - | $1.44 B(-3.7%) | $5.78 B(+2.9%) |
Dec 2005 | $5.63 B(+15.2%) | $1.50 B(+4.1%) | $5.61 B(+1.2%) |
Sept 2005 | - | $1.44 B(+2.8%) | $5.55 B(+4.2%) |
June 2005 | - | $1.40 B(+9.2%) | $5.33 B(+4.7%) |
Mar 2005 | - | $1.28 B(-10.4%) | $5.09 B(+3.8%) |
Dec 2004 | $4.89 B | $1.43 B(+17.5%) | $4.90 B(+5.8%) |
Sept 2004 | - | $1.22 B(+4.8%) | $4.63 B(+4.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2004 | - | $1.16 B(+6.0%) | $4.43 B(+3.9%) |
Mar 2004 | - | $1.09 B(-5.8%) | $4.26 B(+5.3%) |
Dec 2003 | $4.05 B(+26.6%) | $1.16 B(+14.5%) | $4.05 B(+6.9%) |
Sept 2003 | - | $1.01 B(+2.3%) | $3.79 B(+4.4%) |
June 2003 | - | $992.25 M(+12.8%) | $3.63 B(+10.3%) |
Mar 2003 | - | $879.28 M(-2.3%) | $3.29 B(+5.4%) |
Dec 2002 | $3.20 B(+12.3%) | $900.34 M(+5.5%) | $3.12 B(+3.9%) |
Sept 2002 | - | $853.80 M(+30.8%) | $3.00 B(+1.9%) |
June 2002 | - | $652.97 M(-8.1%) | $2.94 B(-0.7%) |
Mar 2002 | - | $710.22 M(-9.2%) | $2.96 B(+1.7%) |
Dec 2001 | $2.85 B(+10.5%) | $781.92 M(-1.9%) | $2.91 B(+22.2%) |
Sept 2001 | - | $796.80 M(+18.5%) | $2.38 B(-30.9%) |
June 2001 | - | $672.68 M(+1.7%) | $3.45 B(-3.8%) |
Mar 2001 | - | $661.56 M(+161.4%) | $3.59 B(-2.1%) |
Dec 2000 | $2.58 B(+9.4%) | $253.11 M(-86.4%) | $3.66 B(+3.0%) |
Sept 2000 | - | $1.86 B(+129.8%) | $3.56 B(+41.4%) |
June 2000 | - | $810.58 M(+9.9%) | $2.52 B(+4.0%) |
Mar 2000 | - | $737.25 M(+398.7%) | $2.42 B(+1.6%) |
Dec 1999 | $2.36 B(+15.6%) | $147.83 M(-82.0%) | $2.38 B(+2.2%) |
Sept 1999 | - | $821.66 M(+15.0%) | $2.33 B(+3.1%) |
June 1999 | - | $714.35 M(+2.2%) | $2.26 B(+2.1%) |
Mar 1999 | - | $699.25 M(+619.8%) | $2.22 B(+4.4%) |
Dec 1998 | $2.04 B(-20.8%) | $97.15 M(-87.1%) | $2.12 B(-22.2%) |
Sept 1998 | - | $750.72 M(+12.4%) | $2.73 B(+4.7%) |
June 1998 | - | $668.15 M(+10.4%) | $2.60 B(+1.4%) |
Mar 1998 | - | $605.00 M(-13.7%) | $2.57 B(+1.2%) |
Dec 1997 | $2.58 B(+0.2%) | $701.25 M(+11.8%) | $2.54 B(-0.6%) |
Sept 1997 | - | $627.41 M(-0.7%) | $2.55 B(-0.3%) |
June 1997 | - | $631.76 M(+9.9%) | $2.56 B(+1.4%) |
Mar 1997 | - | $575.07 M(-19.7%) | $2.52 B(-1.2%) |
Dec 1996 | $2.57 B(+5.0%) | $716.07 M(+12.7%) | $2.55 B(+4.0%) |
Sept 1996 | - | $635.32 M(+6.3%) | $2.46 B(+2.4%) |
June 1996 | - | $597.46 M(-1.2%) | $2.40 B(-2.2%) |
Mar 1996 | - | $604.87 M(-2.1%) | $2.45 B(+1.2%) |
Dec 1995 | $2.45 B(+15.0%) | $617.87 M(+6.7%) | $2.42 B(+1.2%) |
Sept 1995 | - | $578.90 M(-11.3%) | $2.40 B(+1.3%) |
June 1995 | - | $652.47 M(+13.4%) | $2.36 B(+5.7%) |
Mar 1995 | - | $575.16 M(-2.3%) | $2.24 B(+5.3%) |
Dec 1994 | $2.13 B(+4.9%) | $588.55 M(+7.4%) | $2.13 B(-2.0%) |
Sept 1994 | - | $547.95 M(+4.2%) | $2.17 B(+4.0%) |
June 1994 | - | $525.81 M(+13.5%) | $2.09 B(+2.0%) |
Mar 1994 | - | $463.15 M(-26.8%) | $2.04 B(+2.3%) |
Dec 1993 | $2.03 B(+14.6%) | $633.01 M(+36.2%) | $2.00 B(+9.9%) |
Sept 1993 | - | $464.66 M(-4.0%) | $1.82 B(+0.6%) |
June 1993 | - | $484.02 M(+15.9%) | $1.81 B(+1.9%) |
Mar 1993 | - | $417.53 M(-7.9%) | $1.78 B(-0.3%) |
Dec 1992 | $1.77 B(+15.0%) | $453.56 M(-0.2%) | $1.78 B(-0.8%) |
Sept 1992 | - | $454.35 M(+0.8%) | $1.80 B(+5.8%) |
June 1992 | - | $450.60 M(+6.3%) | $1.70 B(+7.1%) |
Mar 1992 | - | $423.75 M(-9.3%) | $1.58 B(+2.4%) |
Dec 1991 | $1.54 B(+14.2%) | $467.25 M(+31.5%) | $1.55 B(+4.3%) |
Sept 1991 | - | $355.38 M(+5.1%) | $1.48 B(+1.5%) |
June 1991 | - | $338.30 M(-12.5%) | $1.46 B(+1.4%) |
Mar 1991 | - | $386.54 M(-4.3%) | $1.44 B(+6.6%) |
Dec 1990 | $1.35 B(+29.3%) | $403.94 M(+20.9%) | $1.35 B(+7.9%) |
Sept 1990 | - | $334.06 M(+5.1%) | $1.25 B(+8.7%) |
June 1990 | - | $317.76 M(+6.8%) | $1.15 B(+7.8%) |
Mar 1990 | - | $297.53 M(-2.4%) | $1.07 B(+2.1%) |
Dec 1989 | $1.04 B(+24.5%) | $304.81 M(+30.4%) | $1.05 B(+6.7%) |
Sept 1989 | - | $233.75 M(-0.0%) | $981.87 M(+5.2%) |
June 1989 | - | $233.82 M(-15.0%) | $933.24 M(+2.3%) |
Mar 1989 | - | $275.14 M(+15.0%) | $912.23 M(+10.9%) |
Dec 1988 | $838.16 M(+13.9%) | $239.16 M(+29.2%) | $822.23 M(+3.5%) |
Sept 1988 | - | $185.12 M(-13.0%) | $794.23 M(+0.6%) |
June 1988 | - | $212.81 M(+15.0%) | $789.74 M(+5.5%) |
Mar 1988 | - | $185.13 M(-12.3%) | $748.69 M(+1.2%) |
Dec 1987 | $735.83 M(+41.8%) | $211.16 M(+16.9%) | $740.04 M(+11.0%) |
Sept 1987 | - | $180.64 M(+5.2%) | $666.80 M(+8.3%) |
June 1987 | - | $171.75 M(-2.7%) | $615.56 M(+6.6%) |
Mar 1987 | - | $176.49 M(+28.0%) | $577.58 M(+11.1%) |
Dec 1986 | $519.04 M(+31.2%) | $137.92 M(+6.6%) | $519.67 M(+5.4%) |
Sept 1986 | - | $129.40 M(-3.3%) | $493.06 M(+7.3%) |
June 1986 | - | $133.77 M(+12.8%) | $459.60 M(+9.2%) |
Mar 1986 | - | $118.58 M(+6.5%) | $421.07 M(+6.6%) |
Dec 1985 | $395.57 M(+8.3%) | $111.30 M(+16.0%) | $394.99 M(+5.4%) |
Sept 1985 | - | $95.94 M(+0.7%) | $374.78 M(+1.2%) |
June 1985 | - | $95.24 M(+3.0%) | $370.38 M(+1.1%) |
Mar 1985 | - | $92.51 M(+1.5%) | $366.30 M(+0.1%) |
Dec 1984 | $365.11 M | $91.09 M(-0.5%) | $365.94 M(+33.1%) |
Sept 1984 | - | $91.54 M(+0.4%) | $274.84 M(+49.9%) |
June 1984 | - | $91.16 M(-1.1%) | $183.30 M(+98.9%) |
Mar 1984 | - | $92.14 M | $92.14 M |
FAQ
- What is Novo Nordisk A/S annual revenue?
- What is the all time high annual revenue for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual revenue year-on-year change?
- What is Novo Nordisk A/S quarterly revenue?
- What is the all time high quarterly revenue for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly revenue year-on-year change?
- What is Novo Nordisk A/S TTM revenue?
- What is the all time high TTM revenue for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM revenue year-on-year change?
What is Novo Nordisk A/S annual revenue?
The current annual revenue of NVO is $33.72 B
What is the all time high annual revenue for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual revenue is $33.72 B
What is Novo Nordisk A/S annual revenue year-on-year change?
Over the past year, NVO annual revenue has changed by +$8.64 B (+34.43%)
What is Novo Nordisk A/S quarterly revenue?
The current quarterly revenue of NVO is $10.51 B
What is the all time high quarterly revenue for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly revenue is $10.51 B
What is Novo Nordisk A/S quarterly revenue year-on-year change?
Over the past year, NVO quarterly revenue has changed by +$1.93 B (+22.53%)
What is Novo Nordisk A/S TTM revenue?
The current TTM revenue of NVO is $39.36 B
What is the all time high TTM revenue for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM revenue is $39.36 B
What is Novo Nordisk A/S TTM revenue year-on-year change?
Over the past year, NVO TTM revenue has changed by +$8.54 B (+27.70%)